Back
CASI Pharmaceuticals Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
35
CASI
CASI Pharmaceuticals
Last Price:
$2.94
Seasonality Move:
14.38%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASI is experiencing slight selling pressure.
CASI Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.85 | Buy |
| 20-day SMA: | 3.19 | Sell |
| 50-day SMA: | 4.59 | Sell |
| 200-day SMA: | 4.7 | Sell |
| 8-day EMA: | 2.94 | Buy |
| 20-day EMA: | 3.32 | Sell |
| 50-day EMA: | 4.23 | Sell |
| 200-day EMA: | 4.87 | Sell |
CASI Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 38.04 | Sell |
| Chaikin Money Flow: | -15950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.77 - 4.15) | Sell |
| Bollinger Bands (100): | (4.17 - 6.75) | Sell |
CASI Pharmaceuticals Technical Analysis
| Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CASI Pharmaceuticals Stock
Is CASI Pharmaceuticals Stock a Buy?
-
CASI Pharmaceuticals share price is 2.98 while CASI 8-day simple moving average is 2.85, which is a Buy signal.
-
The stock price of CASI is 2.98 while CASI Pharmaceuticals 20-day SMA is 3.19, which makes it a Sell.
-
CASI Pharmaceuticals 50-day simple moving average is 4.59 while CASI share price is 2.98, making it a Sell technically.
-
CASI stock price is 2.98 and CASI Pharmaceuticals 200-day simple moving average is 4.70, creating a Sell signal.
CASI Technical Analysis vs Fundamental Analysis
Sell
35
CASI Pharmaceuticals (CASI)
is a Sell
Is CASI Pharmaceuticals a Buy or a Sell?
-
CASI Pharmaceuticals stock is rated a SellThe current CASI Pharmaceuticals [CASI] share price is $2.98. The Score for CASI is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
CASI Pharmaceuticals Stock Info
Market Cap:
46.2M
Price in USD:
2.98
Share Volume:
49K
CASI Pharmaceuticals 52-Week Range
52-Week High:
8.19
52-Week Low:
2.05
Sell
35
CASI Pharmaceuticals (CASI)
is a Sell
CASI Pharmaceuticals Share Price Forecast
-
What is the CASI Pharmaceuticals stock price today?The CASI Pharmaceuticals stock price is 2.98 USD today.
-
Will CASI stock go up or go down?CASI Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is CASI Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CASI Pharmaceuticals is overvalued.
Is CASI Pharmaceuticals Stock a Buy?
-
CASI Pharmaceuticals share price is 2.98 while CASI 8-day exponential moving average is 2.94, which is a Buy signal.
-
The stock price of CASI is 2.98 while CASI Pharmaceuticals 20-day EMA is 3.32, which makes it a Sell.
-
CASI Pharmaceuticals 50-day exponential moving average is 4.23 while CASI share price is 2.98, making it a Sell technically.
-
CASI stock price is 2.98 and CASI Pharmaceuticals 200-day simple moving average is 4.87, creating a Sell signal.
Fundamental Analysis of CASI Pharmaceuticals
Is CASI Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.
Technical Analysis of CASI Pharmaceuticals
Should I short CASI Pharmaceuticals stock?
-
CASI Moving Average Covergence Divergence (MACD) indicator is -0.51, suggesting CASI Pharmaceuticals is a Sell
-
CASI Pharmaceuticals Relative Strength Index (RSI) is 38.04, which suggest CASI Pharmaceuticals is oversold
-
The Bollinger Bands (25) for CASI Pharmaceuticals is (2.77 - 4.15), which suggest CASI Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for CASI Pharmaceuticals is (4.17 - 6.75), which suggest CASI Pharmaceuticals is a Sell
* CASI Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.